Michael P. Krigbaum

Michael P. Krigbaum

Education

University of California, Berkeley (B.A., 2004)
Santa Clara University School of Law (J.D., 2007)

Bar Admissions

California

Michael Krigbaum is a partner in the Corporate Department of Morrison & Foerster’s Palo Alto office. His practice focuses on mergers and acquisitions and venture capital transactions, as well as emerging company counseling. Mr. Krigbaum’s M&A experience includes private and public acquisitions of technology and life sciences companies on both the buy-side and target-side. His expertise includes domestic and cross-border deal structuring and mechanics relating to stock and asset purchases, mergers, divestitures, tender offers, joint ventures, spin-offs and restructurings.

Mr. Krigbaum also represents a number of venture capital firms, corporate venture capital divisions and emerging companies, both in the technology and life science industries, with respect to venture capital transactions, negotiations and structuring, as well as general emerging company counseling.

Representative Transactions

Mergers and Acquisitions

  • VMware, Inc. in its $1.54 billion acquisition of AirWatch, a mobile device management provider.
  • VMware, Inc. in its acquisition of Desktone, Inc., a Massachusetts-based company that pioneered Desktops as a Service (DaaS), delivering desktops and applications as a cloud service.
  • Fyber, a German mobile advertising company, in its acquisition of Heyzap, Inc., a mobile advertising network company based in San Francisco. 
  • Santen Pharmaceutical Co. Ltd., a Japanese ophthalmic pharmaceutical company, in its acquisition of InnFocus, a medical device company.
  • Walmart and its Global eCommerce division in an acquisition of a Chinese ecommerce company and a later strategic alliance with JD.com, China’s largest e-commerce company by revenue, in a transaction that included Walmart’s acquisition of an equity stake in JD.com valued at approximately $1.5 billion.
  • McKesson Corporation, a leading international healthcare services and information technology company, in its acquisitions of Biologics, Inc., an oncology pharmacy services company.
  • McKesson Corporation in its acquisition of LABSCO, a privately held, Kentucky-based distributor of diagnostic equipment for community hospital labs and private office labs.
  • McKesson Corporation in the $130 million sale of ZEE Medical to Cintas Corporation, the publicly traded uniform and first aid products company.
  • McKesson Corporation in the restructuring and divestiture of McKesson’s VITAL Platform to private equity firm Comvest Investment Partners.
  • Intel Corporation in its acquisition of the HTML5 developer tools business of appMobi, Inc., a Lancaster, Pa. company that provides development tools and cloud-based services built on HTML5, CSS and Javascript.
  • Intel Corporation in its acquisition of Basis Science, Inc., a wearable fitness watch company.
  • Intel Corporation in its acquisition of Mashery, Inc. via a reverse triangular merger.
  • Intel Corporation in the acquisition of a Korean computer vision company.
  • Intel Corporation in the asset purchase of a digital media design company.
  • Link_A_Media, the California-based storage solution company, in its acquisition by SK Hynix Inc., a Korea-based semiconductor supplier.
  • Mykonos Software, Inc., the leading provider of Intrusion Deception Systems that protects websites and web applications, in its $80 million acquisition by Juniper Networks, Inc., a leader in network innovation.
  • Mobile Money Ventures, LLC, a joint venture that combined the strengths of Citigroup, a leading, global financial services company, and SK Telecom Americas, an early stage technology innovator, in its sale of assets to Intuit, Inc.
  • InSound Medical, Inc., a developer and manufacturer of next-generation hearing solutions, in its acquisition by Phonak AG, a subsidiary of Sonova AG.

Venture Capital

  • Taiho Ventures, in its strategic investment in Harpoon Therapeutics’ $45 million Series B financing.
  • Spectrum28, an early stage investment fund, in multiple seed investments.
  • Longitude Capital in multiple venture capital investments, including both early- and late-stage investments, and including cross-border investments.
  • Astellas Ventures, an investment arm of Astellas Pharma, in multiple venture capital investments, including both early- and late-stage investments.
  • Santen Pharmaceutical in multiple venture capital investments, including both early- and late-stage investments.
  • Taiho Pharmaceuticals in multiple venture capital investments.
  • New Enterprise Associates and Oak Investment Partners as sellers and continuing shareholders in a strategic alliance between their portfolio company Lianlian Group, a China-based mobile services company, and American Express.
  • Snaplogic, a cloud and data integration company, in its Series A, Series B and Series C financing rounds.
  • DNAnexus, a provider of cloud-based genome informatics and data management, in its incorporation and Series A and Series B financing rounds.
  • Sight Sciences, an ophthalmic medical device company, in its Series A and Series B financing rounds.
  • Sugarfina, Inc., a luxury candy brand that now operates over 30 boutiques and Nordstrom shop-in-shops across North America, in its Series B Preferred Stock financing.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.